FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Microbiology (Reading) / Identification of Rhodococcus equi lipids recognized by host...
Microbiology (Reading, England)2010; 156(Pt 6); 1836-1847; doi: 10.1099/mic.0.035915-0

Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes.

Abstract: Immune adult horses have CD8(+) cytotoxic T lymphocytes (CTLs) that recognize and lyse Rhodococcus equi-infected cells in an equine lymphocyte alloantigen (ELA)-A [classical major histocompatibility complex (MHC) class I]-unrestricted fashion. As protein antigens are MHC class I-restricted, the lack of restriction suggests that the bacterial antigens being recognized by the host are not proteins. The goals of this study were to test the hypothesis that these CTLs recognize unique R. equi cell-wall lipids related to mycobacterial lipids. Initial experiments showed that treatment of soluble R. equi antigen with broadly reactive proteases did not significantly diminish the ability of the antigen to stimulate R. equi-specific CTLs. R. equi-specific CTLs were also shown to lyse target cells (equine macrophages) pulsed with an R. equi lipid extract. Analysis of the R. equi lipid by TLC and MS (MALDI-TOF and ES) indicated that the extracted antigen consisted of three primary fractions: trehalose monomycolate (TMM), trehalose dimycolate (TDM) and cardiolipin (CL). ELA-A-mismatched cells pulsed with purified TMM and CL, but not the TDM fraction, were recognized and lysed by R. equi-specific CTLs. Because of their role in immune clearance and pathogenesis, transcription of the cytokines gamma interferon (IFN-gamma) and interleukin-4 (IL-4) was also measured in response to R. equi lipids by using real-time PCR; elevated IFN-gamma, but not IL-4, was associated with host clearance of the bacteria. The whole-cell R. equi lipid and all three R. equi lipid fractions resulted in marked increases in IFN-gamma transcription, but no increase in IL-4 transcription. Together, these data support the hypothesis that immune recognition of unique lipids in the bacterial cell wall is an important component of the protective immune response to R. equi. The results also identify potential lipid antigens not previously shown to be recognized by CTLs in an important, naturally occurring actinomycete bacterial pathogen.
Get Full Text
Publication Date: 2010-03-18 PubMed ID: 20299405PubMed Central: PMC4086205DOI: 10.1099/mic.0.035915-0Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers investigated the immune response of adult horses to Rhodococcus equi, a type of bacteria, with a focus on identifying the bacterial lipids that cytotoxic T lymphocytes (immune system cells) recognize. Results showed the immune system recognition of unique lipids present within the bacterial cell wall, particularly trehalose monomycolate and cardiolipin, plays a key role in effective immune responses.

Research Objectives and Hypothesis

  • The primary aim of the research was to establish whether cytotoxic T lymphocytes recognize unique cell-wall lipids in Rhodococcus equi, which relate to mycobacterial lipids, based on the fact that the immune response was not restricted in the way it typically is for protein antigens.

Methodology

  • Initial experiments involved treating soluble R. equi antigens with proteases to see if the immune response would weaken. This was not the case, which suggested that proteins were not the antigens triggering the response.
  • Researchers extracted the lipid from R. equi and exposed it to T lymphocytes, and revealed that the lymphocytes were able to destroy target cells (macrophages) pulsed with the lipid.
  • The team used thin-layer chromatography and mass spectroscopy to further analyze the lipid, finding it contained mainly trehalose monomycolate (TMM), trehalose dimycolate (TDM) and cardiolipin (CL).
  • Cells exposed to TMM and CL were recognized and destroyed by the T lymphocytes, but those exposed to TDM were not.
  • The researchers also measured cytokine (a type of immune response protein) transcription in response to the R. equi lipids. The study showed increased transcription of interferon-gamma but not interleukin-4, the former being associated with bacterial clearance.

Findings and Conclusion

  • The results pointed to the immune system’s recognition of these unique bacterial cell wall lipids as a significant part of the protective response against R. equi.
  • The findings also identified potential lipid antigens that have not previously been recognized as key elements in the immune response to this bacterial pathogen. The two isolated lipid fractions, TMM and CL, were shown to trigger the response of cytotoxic T lymphocytes without any restriction, leading to the destruction of infected cells.

These results help broaden the overall understanding of how the immune systems of horses (and potentially other organisms) combat bacterial infections on the cellular level. This could lead to improved treatment strategies for diseases caused by similar bacteria.

Cite This Article

APA
Harris SP, Fujiwara N, Mealey RH, Alperin DC, Naka T, Goda R, Hines SA. (2010). Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes. Microbiology (Reading), 156(Pt 6), 1836-1847. https://doi.org/10.1099/mic.0.035915-0

Publication

Microbiology (Reading, England)
ISSN: 1465-2080
NlmUniqueID: 9430468
Country: England
Language: English
Volume: 156
Issue: Pt 6
Pages: 1836-1847

Researcher Affiliations

Harris, Seth P
  • Department of Veterinary Microbiology and Pathology, Washington State University, College of Veterinary Medicine, PO Box 647040, Pullman, WA 99164-7040, USA.
Fujiwara, Nagatoshi
  • Department of Bacteriology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-Ku, Osaka 545-8585, Japan.
Mealey, Robert H
  • Department of Veterinary Microbiology and Pathology, Washington State University, College of Veterinary Medicine, PO Box 647040, Pullman, WA 99164-7040, USA.
Alperin, Debra C
  • Department of Veterinary Microbiology and Pathology, Washington State University, College of Veterinary Medicine, PO Box 647040, Pullman, WA 99164-7040, USA.
Naka, Takashi
  • Department of Bacteriology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-Ku, Osaka 545-8585, Japan.
Goda, Reina
  • Department of Bacteriology, Osaka City University, Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-Ku, Osaka 545-8585, Japan.
Hines, Stephen A
  • Department of Veterinary Microbiology and Pathology, Washington State University, College of Veterinary Medicine, PO Box 647040, Pullman, WA 99164-7040, USA.

MeSH Terms

  • Animals
  • Antigens, Bacterial / immunology
  • Cell Wall / immunology
  • Horses / immunology
  • Horses / microbiology
  • Interferon-gamma / immunology
  • Interleukin-4 / genetics
  • Interleukin-4 / immunology
  • Leukocytes, Mononuclear / immunology
  • Lipids / immunology
  • Rhodococcus equi / cytology
  • Rhodococcus equi / immunology
  • T-Lymphocytes, Cytotoxic / immunology

Grant Funding

  • T32 AI007025 / NIAID NIH HHS
  • T32 AI007025-24 / NIAID NIH HHS

References

This article includes 53 references
  1. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.. Nature 1994 Dec 15;372(6507):691-4.
    pubmed: 7527500doi: 10.1038/372691a0google scholar: lookup
  2. Bhatt A, Fujiwara N, Bhatt K, Gurcha SS, Kremer L, Chen B, Chan J, Porcelli SA, Kobayashi K, Besra GS, Jacobs WR Jr. Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice.. Proc Natl Acad Sci U S A 2007 Mar 20;104(12):5157-62.
    pmc: PMC1829279pubmed: 17360388doi: 10.1073/pnas.0608654104google scholar: lookup
  3. Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing.. Tuberculosis (Edinb) 2003;83(1-3):98-106.
    pubmed: 12758197doi: 10.1016/s1472-9792(02)00054-9google scholar: lookup
  4. Brennan PJ, Nikaido H. The envelope of mycobacteria.. Annu Rev Biochem 1995;64:29-63.
    pubmed: 7574484doi: 10.1146/annurev.bi.64.070195.000333google scholar: lookup
  5. Bricard G, Porcelli SA. Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity.. Cell Mol Life Sci 2007 Jul;64(14):1824-40.
    pubmed: 17483872doi: 10.1007/s00018-007-7007-0google scholar: lookup
  6. Brigl M, Brenner MB. CD1: antigen presentation and T cell function.. Annu Rev Immunol 2004;22:817-90.
    pubmed: 15032598doi: 10.1146/annurev.immunol.22.012703.104608google scholar: lookup
  7. Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.. J Immunol 2001 Sep 1;167(5):2734-42.
    pubmed: 11509617doi: 10.4049/jimmunol.167.5.2734google scholar: lookup
  8. Catucci L, Depalo N, Lattanzio VM, Agostiano A, Corcelli A. Neosynthesis of cardiolipin in Rhodobacter sphaeroides under osmotic stress.. Biochemistry 2004 Nov 30;43(47):15066-72.
    pubmed: 15554714doi: 10.1021/bi048802kgoogle scholar: lookup
  9. Dascher CC, Hiromatsu K, Xiong X, Morehouse C, Watts G, Liu G, McMurray DN, LeClair KP, Porcelli SA, Brenner MB. Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis.. Int Immunol 2003 Aug;15(8):915-25.
    pubmed: 12882829doi: 10.1093/intimm/dxg091google scholar: lookup
  10. DITTMER JC, LESTER RL. A SIMPLE, SPECIFIC SPRAY FOR THE DETECTION OF PHOSPHOLIPIDS ON THIN-LAYER CHROMATOGRAMS.. J Lipid Res 1964 Jan;5:126-7.
    pubmed: 14173318
  11. Fischer K, Chatterjee D, Torrelles J, Brennan PJ, Kaufmann SH, Schaible UE. Mycobacterial lysocardiolipin is exported from phagosomes upon cleavage of cardiolipin by a macrophage-derived lysosomal phospholipase A2.. J Immunol 2001 Aug 15;167(4):2187-92.
    pubmed: 11490004doi: 10.4049/jimmunol.167.4.2187google scholar: lookup
  12. FOLCH J, LEES M, SLOANE STANLEY GH. A simple method for the isolation and purification of total lipides from animal tissues.. J Biol Chem 1957 May;226(1):497-509.
    pubmed: 13428781
  13. Grotzke JE, Lewinsohn DM. Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection.. Microbes Infect 2005 Apr;7(4):776-88.
    pubmed: 15823514doi: 10.1016/j.micinf.2005.03.001google scholar: lookup
  14. Hava DL, Brigl M, van den Elzen P, Zajonc DM, Wilson IA, Brenner MB. CD1 assembly and the formation of CD1-antigen complexes.. Curr Opin Immunol 2005 Feb;17(1):88-94.
    pubmed: 15653316doi: 10.1016/j.coi.2004.12.003google scholar: lookup
  15. Hines MT, Paasch KM, Alperin DC, Palmer GH, Westhoff NC, Hines SA. Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses.. Vet Immunol Immunopathol 2001 May 10;79(1-2):101-14.
    pubmed: 11356253doi: 10.1016/s0165-2427(01)00258-6google scholar: lookup
  16. Hines SA, Stone DM, Hines MT, Alperin DC, Knowles DP, Norton LK, Hamilton MJ, Davis WC, McGuire TC. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes.. Clin Diagn Lab Immunol 2003 Mar;10(2):208-15.
    pmc: PMC150533pubmed: 12626444doi: 10.1128/cdli.10.2.208-215.2003google scholar: lookup
  17. Hiromatsu K, Dascher CC, LeClair KP, Sugita M, Furlong ST, Brenner MB, Porcelli SA. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens.. J Immunol 2002 Jul 1;169(1):330-9.
    pubmed: 12077262doi: 10.4049/jimmunol.169.1.330google scholar: lookup
  18. Hondalus MK. Pathogenesis and virulence of Rhodococcus equi.. Vet Microbiol 1997 Jun 16;56(3-4):257-68.
    pubmed: 9226840doi: 10.1016/s0378-1135(97)00094-1google scholar: lookup
  19. Hooper-McGrevy KE, Wilkie BN, Prescott JF. Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi.. Vaccine 2005 Dec 30;23(50):5760-7.
    pubmed: 16112256doi: 10.1016/j.vaccine.2005.07.050google scholar: lookup
  20. Kanaly ST, Hines SA, Palmer GH. Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice.. Infect Immun 1993 Nov;61(11):4929-32.
    pmc: PMC281259pubmed: 8104903doi: 10.1128/iai.61.11.4929-4932.1993google scholar: lookup
  21. Kanaly ST, Hines SA, Palmer GH. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia.. Infect Immun 1995 Aug;63(8):3037-41.
    pmc: PMC173413pubmed: 7622227doi: 10.1128/iai.63.8.3037-3041.1995google scholar: lookup
  22. Kanaly ST, Hines SA, Palmer GH. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung.. Infect Immun 1996 Apr;64(4):1126-32.
    pmc: PMC173893pubmed: 8606068doi: 10.1128/iai.64.4.1126-1132.1996google scholar: lookup
  23. Karakousis PC, Bishai WR, Dorman SE. Mycobacterium tuberculosis cell envelope lipids and the host immune response.. Cell Microbiol 2004 Feb;6(2):105-16.
    pubmed: 14706097doi: 10.1046/j.1462-5822.2003.00351.xgoogle scholar: lookup
  24. Kurano S, Sugimoto N, Sumi Y, Sawai H, Kato Y, Kaneda K, Yano I. [Newly isolated glycolipids from Rhodococcus terrae cell wall and their granuloma forming activities].. Yakugaku Zasshi 1987 Jan;107(1):46-52.
    pubmed: 3585708doi: 10.1248/yakushi1947.107.1_46google scholar: lookup
  25. Li B, Rossman MD, Imir T, Oner-Eyuboglu AF, Lee CW, Biancaniello R, Carding SR. Disease-specific changes in gammadelta T cell repertoire and function in patients with pulmonary tuberculosis.. J Immunol 1996 Nov 1;157(9):4222-9.
    pubmed: 8892660
  26. Linder R. Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection.. Emerg Infect Dis 1997 Apr-Jun;3(2):145-53.
    pmc: PMC2627624pubmed: 9204295doi: 10.3201/eid0302.970207google scholar: lookup
  27. Lopez AM, Hines MT, Palmer GH, Alperin DC, Hines SA. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.. Clin Diagn Lab Immunol 2002 Nov;9(6):1270-6.
    pmc: PMC130094pubmed: 12414760doi: 10.1128/cdli.9.6.1270-1276.2002google scholar: lookup
  28. McGuire TC, Tumas DB, Byrne KM, Hines MT, Leib SR, Brassfield AL, O'Rourke KI, Perryman LE. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.. J Virol 1994 Mar;68(3):1459-67.
    pmc: PMC236601pubmed: 8107209doi: 10.1128/JVI.68.3.1459-1467.1994google scholar: lookup
  29. Moody DB, Porcelli SA. Intracellular pathways of CD1 antigen presentation.. Nat Rev Immunol 2003 Jan;3(1):11-22.
    pubmed: 12511872doi: 10.1038/nri979google scholar: lookup
  30. Moody DB, Reinhold BB, Reinhold VN, Besra GS, Porcelli SA. Uptake and processing of glycosylated mycolates for presentation to CD1b-restricted T cells.. Immunol Lett 1999 Jan;65(1-2):85-91.
    pubmed: 10065632doi: 10.1016/s0165-2478(98)00129-1google scholar: lookup
  31. Moody DB, Briken V, Cheng TY, Roura-Mir C, Guy MR, Geho DH, Tykocinski ML, Besra GS, Porcelli SA. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation.. Nat Immunol 2002 May;3(5):435-42.
    pubmed: 11938350doi: 10.1038/ni780google scholar: lookup
  32. Natsuhara Y, Yoshinaga J, Shogaki T, Sumi-Nishikawa Y, Kurano S, Kato Y, Kaneda K, Oka S, Yano I. Granuloma-forming activity and antitumor activity of newly isolated mycoloyl glycolipid from Rhodococcus terrae 70012 (Rt. GM-2).. Microbiol Immunol 1990;34(1):45-53.
    pubmed: 2325578doi: 10.1111/j.1348-0421.1990.tb00990.xgoogle scholar: lookup
  33. Nishiuchi Y, Baba T, Yano I. Mycolic acids from Rhodococcus, Gordonia, and Dietzia.. J Microbiol Methods 2000 Mar;40(1):1-9.
    pubmed: 10739337doi: 10.1016/s0167-7012(99)00116-5google scholar: lookup
  34. Patton KM, McGuire TC, Fraser DG, Hines SA. Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion.. Infect Immun 2004 Dec;72(12):7073-83.
    pmc: PMC529141pubmed: 15557631doi: 10.1128/IAI.72.12.7073-7083.2004google scholar: lookup
  35. Patton KM, McGuire TC, Hines MT, Mealey RH, Hines SA. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals.. Infect Immun 2005 Apr;73(4):2083-93.
    pmc: PMC1087435pubmed: 15784549doi: 10.1128/IAI.73.4.2083-2093.2005google scholar: lookup
  36. Perez MG, Vassilev T, Kemmerly SA. Rhodococcus equi infection in transplant recipients: a case of mistaken identity and review of the literature.. Transpl Infect Dis 2002 Mar;4(1):52-6.
    pubmed: 12123427doi: 10.1034/j.1399-3062.2002.01001.xgoogle scholar: lookup
  37. Porcelli SA. Cutting glycolipids down to size.. Nat Immunol 2001 Mar;2(3):191-2.
    pubmed: 11224512doi: 10.1038/85234google scholar: lookup
  38. Rahman MT, Herron LL, Kapur V, Meijer WG, Byrne BA, Ren J, Nicholson VM, Prescott JF. Partial genome sequencing of Rhodococcus equi ATCC 33701.. Vet Microbiol 2003 Jul 1;94(2):143-58.
    pubmed: 12781482doi: 10.1016/s0378-1135(03)00100-7google scholar: lookup
  39. Rao V, Fujiwara N, Porcelli SA, Glickman MS. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule.. J Exp Med 2005 Feb 21;201(4):535-43.
    pmc: PMC2213067pubmed: 15710652doi: 10.1084/jem.20041668google scholar: lookup
  40. Roura-Mir C, Moody DB. Sorting out self and microbial lipid antigens for CD1.. Microbes Infect 2003 Oct;5(12):1137-48.
    pubmed: 14554256doi: 10.1016/j.micinf.2003.08.003google scholar: lookup
  41. Serbina NV, Liu CC, Scanga CA, Flynn JL. CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages.. J Immunol 2000 Jul 1;165(1):353-63.
    pubmed: 10861072doi: 10.4049/jimmunol.165.1.353google scholar: lookup
  42. Siliciano RF, Keegan AD, Dintzis RZ, Dintzis HM, Shin HS. The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones.. J Immunol 1985 Aug;135(2):906-14.
    pubmed: 2409158
  43. Skinner MA, Yuan S, Prestidge R, Chuk D, Watson JD, Tan PL. Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis.. Infect Immun 1997 Nov;65(11):4525-30.
    pmc: PMC175650pubmed: 9353029doi: 10.1128/iai.65.11.4525-4530.1997google scholar: lookup
  44. Stenger S, Modlin RL. T cell mediated immunity to Mycobacterium tuberculosis.. Curr Opin Microbiol 1999 Feb;2(1):89-93.
    pubmed: 10047556doi: 10.1016/s1369-5274(99)80015-0google scholar: lookup
  45. Szereday L, Baliko Z, Szekeres-Bartho J. Gamma/delta T cell subsets in patients with active Mycobacterium tuberculosis infection and tuberculin anergy.. Clin Exp Immunol 2003 Feb;131(2):287-91.
    pmc: PMC1808624pubmed: 12562390doi: 10.1046/j.1365-2249.2003.02063.xgoogle scholar: lookup
  46. Takai S. Epidemiology of Rhodococcus equi infections: a review.. Vet Microbiol 1997 Jun 16;56(3-4):167-76.
    pubmed: 9226831doi: 10.1016/s0378-1135(97)00085-0google scholar: lookup
  47. Tonge PJ. Another brick in the wall.. Nat Struct Biol 2000 Feb;7(2):94-6.
    pubmed: 10655605doi: 10.1038/72458google scholar: lookup
  48. Torres-Tortosa M, Arrizabalaga J, Villanueva JL, Gálvez J, Leyes M, Valencia ME, Flores J, Peña JM, Pérez-Cecilia E, Quereda C. Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases.. Chest 2003 Jun;123(6):1970-6.
    pubmed: 12796176doi: 10.1378/chest.123.6.1970google scholar: lookup
  49. Ueda S, Fujiwara N, Naka T, Sakaguchi I, Ozeki Y, Yano I, Kasama T, Kobayashi K. Structure-activity relationship of mycoloyl glycolipids derived from Rhodococcus sp. 4306.. Microb Pathog 2001 Feb;30(2):91-9.
    pubmed: 11162189doi: 10.1006/mpat.2000.0413google scholar: lookup
  50. Ulrichs T, Moody DB, Grant E, Kaufmann SH, Porcelli SA. T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection.. Infect Immun 2003 Jun;71(6):3076-87.
    pmc: PMC155760pubmed: 12761085doi: 10.1128/IAI.71.6.3076-3087.2003google scholar: lookup
  51. Willcox BE, Willcox CR, Dover LG, Besra G. Structures and functions of microbial lipid antigens presented by CD1.. Curr Top Microbiol Immunol 2007;314:73-110.
    pubmed: 17593658doi: 10.1007/978-3-540-69511-0_4google scholar: lookup
  52. Zhang W, Lonning SM, McGuire TC. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.. J Virol 1998 Dec;72(12):9612-20.
    pmc: PMC110470pubmed: 9811694doi: 10.1128/JVI.72.12.9612-9620.1998google scholar: lookup
  53. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria.. Clin Infect Dis 1999 Sep;29(3):490-4.
    pubmed: 10530434doi: 10.1086/598620google scholar: lookup

Citations

This article has been cited 6 times.
  1. Giri SS, Kim HJ, Kim SG, Kim SW, Kwon J, Lee SB, Park SC. Immunomodulatory Role of Microbial Surfactants, with Special Emphasis on Fish.. Int J Mol Sci 2020 Sep 23;21(19).
    doi: 10.3390/ijms21197004pubmed: 32977579google scholar: lookup
  2. Harvey DJ. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.. Mass Spectrom Rev 2015 May-Jun;34(3):268-422.
    doi: 10.1002/mas.21411pubmed: 24863367google scholar: lookup
  3. Dossa RG, Alperin DC, Hines MT, Hines SA. The equine CD1 gene family is the largest and most diverse yet identified.. Immunogenetics 2014 Jan;66(1):33-42.
    doi: 10.1007/s00251-013-0741-6pubmed: 24196432google scholar: lookup
  4. Bordin AI, Suchodolski JS, Markel ME, Weaver KB, Steiner JM, Dowd SE, Pillai S, Cohen ND. Effects of administration of live or inactivated virulent Rhodococccus equi and age on the fecal microbiome of neonatal foals.. PLoS One 2013;8(6):e66640.
    doi: 10.1371/journal.pone.0066640pubmed: 23785508google scholar: lookup
  5. Sydor T, von Bargen K, Hsu FF, Huth G, Holst O, Wohlmann J, Becken U, Dykstra T, Söhl K, Lindner B, Prescott JF, Schaible UE, Utermöhlen O, Haas A. Diversion of phagosome trafficking by pathogenic Rhodococcus equi depends on mycolic acid chain length.. Cell Microbiol 2013 Mar;15(3):458-73.
    doi: 10.1111/cmi.12050pubmed: 23078612google scholar: lookup
  6. Harris SP, Hines MT, Mealey RH, Alperin DC, Hines SA. Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.. Vet Immunol Immunopathol 2011 Jun 15;141(3-4):312-6.
    doi: 10.1016/j.vetimm.2011.03.015pubmed: 21481947google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.